Ceptaris Therapeutics is Drug Discovery in United States that focus on NMDA antagonist business. Founded in 2002. They cover business area such as developer, mechlorethamine hydrochloride, stage, ) mycosis, neuropathic pain, NMDA side-effect, physician, dermatological and central nervous system disease.
2002
( 22 years old in 2024 )
NMDA Antagonist
-
101 Lindenwood Drive
Suite 400
Malvern, PA 19355
United States
Private
developermechlorethamine hydrochloridestage) mycosisneuropathic painNMDA side-effectphysiciandermatological and central nervous system disease
* We use standard office opening hours in near Ceptaris Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ceptaris Therapeutics is Drug Discovery business from United States that founded in 2002 (22 years old in 2024), Ceptaris Therapeutics business is focusing on NMDA Antagonist.
Ceptaris Therapeutics headquarter office and corporate office address is located in 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States.
Ceptaris Therapeutics was founded in United States.
In 2024, Ceptaris Therapeutics is currently focus on NMDA antagonist sector.
Above is snippet of Google Trends for "NMDA antagonist" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ceptaris Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
